The IP&C team has broad expertise in biomedical research, product development, industry partnerships, business development, marketing, start-ups, technology licensing, and commercialization of innovations.
Gaurie is responsible for guiding team members towards development goals to ensure the success of prioritized projects. Before joining IP&C, she worked in product management and strategy in a variety of healthcare settings, such as Medcan Health Management, the Michael G. DeGroote Initiative for Innovation in Healthcare, Joseph Brant Hospital, and Baylis Medical.
Gaurie received her Masters of Business Administration from the DeGroote School of Business at McMaster University, and has a Bachelor’s of Science, double majoring in Biology and Medical Cell Biology from Western University.
Ihor joined SickKids to lead the IP&C office as Executive Director in November 2018, bringing close to two decades of experience in the life sciences sector. Previously, Ihor spent nearly fifteen years in the in vitro diagnostics industry developing, commercializing and partnering innovative molecular technologies at Tm Bioscience (TSXV: TMC), Luminex (NASDAQ: LMNX) and venture-backed start-up Xagenic. He also served as Vice President of Business Development at Ontario Genomics, and is currently a Director of CELS-SFO.
Brad Brinton, PhDSenior Manager, Business Development
Brad Brinton, PhD
Brad has held business development, commercialization and senior scientist positions leading research teams involved in all aspects of drug discovery at several international pharmaceutical companies. Brad’s expertise, gained through over 18 years evaluating, developing and commercializing life science technologies, provides a unique tactical and strategic perspective to the commercialization of technologies emerging from SickKids.
Jevin provides strategic guidance and support for Investigators in identifying and evaluating new inventions, developing technology licensing opportunities and strategies, negotiating the terms and conditions of agreements and finding suitable partners for licensing of technologies developed at SickKids. He primarily focusses on medical apps, clinical tools/devices, clinical health outcome measures (HOMs), quality-of-life questionnaires, research tools and educational tools.
With a strong background in research contract negotiation and market research, Jevin brings an innovative and tactical approach to the commercialization of technologies emerging from SickKids. Jevin received a Bachelor of Science (Honours) degree from the University of Guelph, specializing in Biomedical Science.
Ed Kenney, MBASenior Manager, Business Development
Ed Kenney, MBA
Ed contributes his expertise to a variety of commercialization activities within IP&C, including negotiating Sponsored Research Agreements and Licensing Agreements with industry. Utilizing his engineering background, Ed’s portfolio includes in part the medical devices developed at SickKids. Ed has a BSChE (Chemical Engineering) degree from Northeastern University and an MBA from the State University of New York at Buffalo.
As the Administrative Assistant to the Executive Director, Manuela provides general administrative support to the team. She is also responsible for inputting data related to the Hospital’s intellectual property portfolio into a central resource used for managing patent and intellectual property.
Sedric Pankras, PhD, MBABusiness Development Associate
Sedric Pankras, PhD, MBA
Sedric, with his background in research, business and commercialization, involved in all stages of commercialization activities at IP&C including developing business plans, identifying & developing new partnerships, start-up creation and financial valuations to support deal structuring, negotiation & licensing. In the past he has worked as a Business analyst (TDC – UHN) and as a Consultant (First Principles Advisory Group) to enable commercialization of health technologies, and as a Research Fellow in the area of Life Sciences (UofT).
Sedric received his PhD from the University of Toronto, and an MBA & a Graduate Diploma in Health Industry Management from Schulich School of Business.
In his role as Director of Business Development, Konrad applies his extensive pharma and tech transfer experience in leading the SickKids IP&C business development team. With over 25 years of combined experience as a Biotechnology Commercialization Manager for institutions such as the University of Toronto, The Canadian Arthritis Network, Centre for Addiction and Mental Health (CAMH) and Sinai Health System, and over 15 years as a Contracts Specialist for CAMH and other hospitals affiliated with the University of Toronto, he brings a broad spectrum of knowledge to commercializing early-stage discoveries out of our institution.
Anny supports the design of business strategies and manages day-to-day operations, including business administration, communications, financial and data analysis. She brings a unique blend of experience encompassing the development of information strategies and implementing improvement initiatives. Prior to joining the IP&C team, Anny held various roles in research administration and program/project management. Anny received a Bachelor of Science (Honours) degree from the University of Waterloo, specializing in Life Science and Business
Stephanie has been at SickKids for 14 years, first as a Ph.D. student and then as Lab Manager for the Howell Lab in Molecular Medicine. She brings extensive project management and operational experience to the IP&C team as the Operations Manager. Her responsibilities include financial reporting and data analysis, business administration, and business strategy support for the entire IP&C team.
Tatianna works with researchers to identify and assess new technologies and inventions for commercialization opportunities. She received her BSc and MSc in Biochemistry and Biomedical Science at McMaster University and she holds a PhD in Molecular Genetics from the University of Toronto. Tatianna’s recently completed PhD was specialized in rare diseases and gene editing technologies.